{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:57Z","timestamp":1787041677548,"version":"build-2736575974"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2025GXNSFBA069173"],"award-info":[{"award-number":["2025GXNSFBA069173"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560682"],"award-info":[{"award-number":["82560682"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119105","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:33:48Z","timestamp":1782491628000},"page":"119105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of glycoconjugated metal complexes in cancer therapy"],"prefix":"10.1016","volume":"317","author":[{"given":"Xueyu","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-4107","authenticated-orcid":false,"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2026.119105_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119105_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119105_bib3","first-page":"97","article-title":"Application of nanotechnology in cancer therapy and imaging","volume":"58","author":"Wang","year":"2008","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119105_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119105_bib5","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/1078-0432.CCR-03-0666","article-title":"Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer","volume":"10","author":"Gamelin","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119105_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119105_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216319","article-title":"Recent advances in the development of metallodrugs for cancer chemoimmunotherapy","volume":"526","author":"Wei","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119105_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215579","article-title":"Riding the metal wave: a review of the latest developments in metal-based anticancer agents","volume":"501","author":"Abdolmaleki","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"35","key":"10.1016\/j.ejmech.2026.119105_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504575","article-title":"Metal\u2010ligand complexes as multifunctional platforms for photo\u2010activated cancer therapy","volume":"12","author":"Kim","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119105_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.215941","article-title":"Metal N-heterocyclic carbene complexes as potential metallodrugs in antitumor therapy","volume":"514","author":"Zhang","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119105_bib11","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1021\/acs.jmedchem.4c02696","article-title":"Lactoferrin nanoparticle-vanadium complex: a promising high-efficiency agent against glioblastoma by triggering autophagy and ferroptosis","volume":"68","author":"Gai","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119105_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.151573","article-title":"Benzothiazole hydrazone Cu(II) complex for therapeutic anticancer enhancement via PARP-1 inhibition","volume":"357","author":"Jiang","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119105_bib13","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib14","first-page":"12","article-title":"The metabolism of tumors in the body","volume":"8","author":"Otto Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"2020","key":"10.1016\/j.ejmech.2026.119105_bib15","article-title":"HPV 16 E6\/E7 promote the glucose uptake of GLUT1 in lung cancer through downregulation of TXNIP due to inhibition of PTEN phosphorylation","volume":"10","author":"Tang","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib16","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119105_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"23","key":"10.1016\/j.ejmech.2026.119105_bib18","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1039\/D2CS00379A","article-title":"Glycosidase activated prodrugs for targeted cancer therapy","volume":"51","author":"Martin","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.119105_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108158","article-title":"Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics","volume":"235","author":"Sorieul","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119105_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102236","article-title":"Platinum glycoconjugates: \u201csweet bullets\u201d for targeted cancer therapy?","volume":"72","author":"Vaidya","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119105_bib21","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1039\/c3cc38589b","article-title":"Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties","volume":"49","author":"Liu","year":"2013","journal-title":"Chem. Commun. (Cambridge, U. K.)"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib22","first-page":"620","article-title":"(18)F-FDG-PET\/CT in evaluating response to therapy in solid tumors: where we are and where we can go","volume":"55","author":"Herrmann","year":"2011","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119105_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/COC.0b013e3181979204","article-title":"A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma","volume":"33","author":"Chiorean","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119105_bib24","series-title":"Metal-Based Anticancer Agents","first-page":"308","author":"P\u00f6tsch","year":"2019"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119105_bib25","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3390\/app13095561","article-title":"Recent advances in bioconjugated transition metal complexes for cancer therapy","volume":"13","author":"Bortolamiol","year":"2023","journal-title":"Appl. Sci."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119105_bib26","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3390\/molecules30173537","article-title":"Recent advances in the development of metal-glycoconjugates for medicinal applications","volume":"30","author":"Brescia","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119105_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib28","first-page":"524","article-title":"Breast cancer statistics","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib29","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119105_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejmech.2015.07.006","article-title":"Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action","volume":"101","author":"Li","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119105_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2021.02.030","article-title":"Recent advances of redox-responsive nanoplatforms for tumor theranostics","volume":"332","author":"Chen","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119105_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164910","article-title":"Modulating the tumor microenvironment to augment Fenton catalysis and enhance chemodynamic therapy: a comprehensive review","volume":"519","author":"Tian","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"25","key":"10.1016\/j.ejmech.2026.119105_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202310018","article-title":"Recent progress in anti-tumor nanodrugs based on tumor microenvironment redox regulation","volume":"20","author":"Yao","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ejmech.2026.119105_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejmech.2017.01.032","article-title":"Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo","volume":"128","author":"Ma","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"37","key":"10.1016\/j.ejmech.2026.119105_bib35","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.3c07157","article-title":"Chitosan\u2013biotin-conjugated pH-responsive Ru(II) glucose nanogel: a dual pathway of targeting cancer cells and self-drug delivery","volume":"15","author":"Pragti","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"13","key":"10.1016\/j.ejmech.2026.119105_bib36","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/acs.jmedchem.7b00433","article-title":"Glycosylated platinum(IV) complexes as substrates for glucose transporters (GLUTs) and organic cation transporters (OCTs) exhibited cancer targeting and human serum albumin binding properties for drug delivery","volume":"60","author":"Ma","year":"2017","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119105_bib37","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1039\/D5QI00623F","article-title":"Four-in-one multifunctional iron(iii) complex for cancer theranostics: unique integration of targeted delivery, photodynamic therapy, and dual imaging modalities","volume":"12","author":"Sarkar","year":"2025","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2026.119105_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102666","article-title":"Evolving landscape of colorectal cancer: global and regional burden, risk factor dynamics, and future scenarios (the global burden of disease 1990\u20132050)","volume":"104","author":"Zhou","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119105_bib39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/cmdc.201600079","article-title":"Methyl 6\u2010amino\u20106\u2010deoxy\u2010d\u2010pyranoside\u2010conjugated platinum (II) complexes for glucose transporter (GLUT)\u2010mediated tumor targeting: synthesis, cytotoxicity, and cellular uptake mechanism","volume":"11","author":"Li","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119105_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejmech.2016.01.016","article-title":"Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer","volume":"110","author":"Wu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119105_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2016.09.047","article-title":"Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents","volume":"125","author":"Gao","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119105_bib42","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cmdc.201900226","article-title":"CuII and AuIII complexes with glycoconjugated dithiocarbamato ligands for potential applications in targeted chemotherapy","volume":"14","author":"Pettenuzzo","year":"2019","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119105_bib43","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1021\/acs.jmedchem.0c01875","article-title":"Warburg effect targeting Co (III) cytotoxin chaperone complexes","volume":"64","author":"Glenister","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12943-025-02404-9","article-title":"Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatment","volume":"24","author":"Du","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.119105_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215324","article-title":"Activatable nano-photosensitizers for precise photodynamic cancer therapy","volume":"493","author":"Li","year":"2023","journal-title":"Coord. Chem. Rev."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119105_bib46","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1039\/D5CS00054H","article-title":"Enhancing biosafety in photodynamic therapy: progress and perspectives","volume":"54","author":"Zhao","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.119105_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214860","article-title":"Recent advances on organelle specific Ru(II)\/Ir(III)\/Re(I) based complexes for photodynamic therapy","volume":"474","author":"Kar","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119105_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216572","article-title":"Advanced strategies in the design of Ir(III) biscyclometalated complexes for PDT","volume":"534","author":"Sanz-Villafruela","year":"2025","journal-title":"Coord. Chem. Rev."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119105_bib49","first-page":"3448","article-title":"Glycosylated BODIPY-incorporated Pt (II) metallacycles for targeted and synergistic chemo-photodynamic therapy","volume":"66","author":"Dur\u00e1n-Sampedro","year":"2023","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119105_bib50","first-page":"1433","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"Prostate cancer. JAMA"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119105_bib51","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.3390\/molecules28104122","article-title":"Nanoparticle-based radioconjugates for targeted imaging and therapy of prostate cancer","volume":"28","author":"Lankoff","year":"2023","journal-title":"Molecules"},{"issue":"38","key":"10.1016\/j.ejmech.2026.119105_bib52","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.6b06937","article-title":"Chemical approach to positional isomers of glucose\u2013platinum conjugates reveals specific cancer targeting through glucose-transporter-mediated uptake in vitro and in vivo","volume":"138","author":"Patra","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119105_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112326","article-title":"Carbohydrate effect of novel arene Ru(II) phenanthroline-glycoconjugates on metastatic biological processes","volume":"247","author":"de la Torre-Rubio","year":"2023","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib54","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1080\/10717544.2022.2120566","article-title":"Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer","volume":"29","author":"Wathoni","year":"2022","journal-title":"Drug Deliv."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119105_bib55","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1158\/1078-0432.CCR-22-3699","article-title":"FDA approval summary: atezolizumab as adjuvant treatment following surgical resection and platinum-based chemotherapy for stage II to IIIA NSCLC","volume":"29","author":"Mathieu","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119105_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118237","article-title":"Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer","volume":"268","author":"Zhu","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"51","key":"10.1016\/j.ejmech.2026.119105_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/chem.201603066","article-title":"D\u2010 versus L\u2010glucose conjugation: mitochondrial targeting of a light\u2010activated dual\u2010mode\u2010of\u2010action ruthenium\u2010based anticancer prodrug","volume":"22","author":"Lameijer","year":"2016","journal-title":"Chem. Eur J."},{"issue":"42","key":"10.1016\/j.ejmech.2026.119105_bib58","doi-asserted-by":"crossref","DOI":"10.1039\/D2DT02455A","article-title":"Antitumor effects of new glycoconjugated PtII agents dual-targeting GLUT1 and Pgp proteins","volume":"51","author":"Zhang","year":"2022","journal-title":"Dalton Trans."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119105_bib59","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact","volume":"2","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.ejmech.2026.119105_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jconrel.2022.04.031","article-title":"Advocation and advancements of EPR effect theory in drug delivery science: a commentary","volume":"346","author":"Hashida","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119105_bib61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119105_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2023.07.039","article-title":"Targeting endothelial permeability in the EPR effect","volume":"361","author":"Lahooti","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119105_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"52","key":"10.1016\/j.ejmech.2026.119105_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101460","article-title":"Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery","volume":"17","author":"Li","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.ejmech.2026.119105_bib65","article-title":"Carrier-free nanoparticles based on natural products trigger dual \"synergy and attenuation\" for enhanced phototherapy of liver cancer","volume":"35","author":"Wang","year":"2025","journal-title":"Mater. Today"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib66","first-page":"762","article-title":"Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo","volume":"16","author":"Yang","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2026.119105_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jconrel.2025.01.050","article-title":"Self-assembled HO-1i-Pt(IV) nanomedicine targeting p38\/MAPK and MDR pathways for cancer chemo-immunotherapy","volume":"379","author":"Liu","year":"2025","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119105_bib68","article-title":"Carrier-free ATP-activated nanoparticles for combined photodynamic therapy and chemotherapy under near-infrared light","volume":"19","author":"Su","year":"2023","journal-title":"Small"},{"issue":"46","key":"10.1016\/j.ejmech.2026.119105_bib69","doi-asserted-by":"crossref","DOI":"10.1039\/D1SC02841C","article-title":"Dynamic supramolecular self-assembly of platinum(ii) complexes perturbs an autophagy\u2013lysosomal system and triggers cancer cell death","volume":"12","author":"Tong","year":"2021","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119105_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cac2.12629","article-title":"Advances in cervical cancer: current insights and future directions","volume":"45","author":"Xu","year":"2024","journal-title":"Cancer Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119105_bib71","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119105_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119105_bib73","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/ic4028173","article-title":"Carbohydrate-appended tumor targeting iron(III) complexes showing photocytotoxicity in red light","volume":"53","author":"Basu","year":"2014","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119105_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112226","article-title":"Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene","volume":"244","author":"Sahoo","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119105_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116649","article-title":"Nanotechnology-empowered strategies in treatment of skin cancer","volume":"235","author":"Chandra","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.ejmech.2026.119105_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116454","article-title":"Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and cannabidiol against non-melanoma skin cancer","volume":"233","author":"Hasan","year":"2023","journal-title":"Environ. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib77","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119105_bib78","article-title":"Recent progress in polymeric biomaterials and their potential applications in skin regeneration and wound care management","volume":"82","author":"Tiwari","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2026.119105_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122580","article-title":"Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer","volume":"632","author":"Hasan","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119105_bib80","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","article-title":"Tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel","volume":"52","author":"Rixe","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119105_bib81","first-page":"34","article-title":"A platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling melanoma tumorigenesis, angiogenesis, and radioresistance","volume":"22","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejmech.2026.119105_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.132836","article-title":"A tyrosinase-activated Pt(II) complex for melanoma photodynamic therapy and fluorescence imaging","volume":"374","author":"Liu","year":"2023","journal-title":"Sensor. Actuator. B Chem."},{"issue":"33","key":"10.1016\/j.ejmech.2026.119105_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302895","article-title":"cGAS-STING pathway activation and systemic anti-tumor immunity induction via photodynamic nanoparticles with potent toxic platinum DNA intercalator against uveal melanoma","volume":"10","author":"Tao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119105_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccr.2015.11.004","article-title":"New trends in platinum and palladium complexes as antineoplastic agents","volume":"310","author":"Fanelli","year":"2016","journal-title":"Coord. Chem. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119105_bib85","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41419-018-0303-9","article-title":"Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1\/2-RSK1 pathway","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119105_bib86","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1039\/C9DT01614G","article-title":"A highly efficient and selective antitumor agent based on a glucoconjugated carbene platinum(ii) complex","volume":"48","author":"Annunziata","year":"2019","journal-title":"Dalton Trans."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119105_bib87","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1039\/D1DT04218A","article-title":"Luminescent iridium(III) dipyrrinato complexes: synthesis, X-ray structures, and DFT and photocytotoxicity studies of glycosylated derivatives","volume":"51","author":"Manav","year":"2022","journal-title":"Dalton Trans."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13206-019-3108-8","article-title":"Current immunotherapy approaches for malignant melanoma","volume":"13","author":"Lim","year":"2019","journal-title":"Biochip J."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119105_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202201103","article-title":"Complexes undergo unprecedented photo\u2010induced \u03b2\u2010hydride elimination and reduction for targeted cancer therapy","volume":"61","author":"Jiang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib90","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119105_bib91","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119105_bib92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41575-024-01021-z","article-title":"Current and emerging strategies for the prevention of hepatocellular carcinoma","volume":"22","author":"Yeo","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib93","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1039\/C3DT51973B","article-title":"Carbohydrate linked organotin(iv) complexes as human topoisomerase I\u03b1 inhibitor and their antiproliferative effects against the human carcinoma cell line","volume":"43","author":"Khan","year":"2014","journal-title":"Dalton Trans."},{"issue":"25","key":"10.1016\/j.ejmech.2026.119105_bib94","doi-asserted-by":"crossref","DOI":"10.1039\/C6DT01562J","article-title":"Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents","volume":"45","author":"Wang","year":"2016","journal-title":"Dalton Trans."},{"issue":"10177","key":"10.1016\/j.ejmech.2026.119105_bib95","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119105_bib96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","article-title":"Can advanced-stage ovarian cancer be cured?","volume":"13","author":"Narod","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119105_bib97","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Cancer"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119105_bib98","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/anie.201510551","article-title":"A potent glucose\u2013platinum conjugate exploits glucose transporters and preferentially accumulates in cancer cells","volume":"55","author":"Patra","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119105_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114743","article-title":"Novel glycosylation zinc(II)\u2013cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3\/DDP cells","volume":"243","author":"Zhou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119105_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2026.1724206","article-title":"Thiosugar-functionalized gold(I)-NHC complexes as selective anticancer agents for potential targeted therapy","volume":"14","author":"Giorgi","year":"2026","journal-title":"Front. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119105_bib101","first-page":"381","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119105_bib102","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119105_bib103","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10145","key":"10.1016\/j.ejmech.2026.119105_bib104","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119105_bib105","article-title":"Challenges and advances for glioma therapy based on inorganic nanoparticles","volume":"20","author":"Hu","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119105_bib106","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbapap.2014.01.006","article-title":"Antiglioma activity of GoPI-sugar, a novel gold(I)\u2013phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivo","volume":"1844","author":"Jortzik","year":"2014","journal-title":"BBA Proteins Proteom"},{"key":"10.1016\/j.ejmech.2026.119105_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib108","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-13-237","article-title":"Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells","volume":"13","author":"Tanaka","year":"2013","journal-title":"BMC Cancer"},{"issue":"26","key":"10.1016\/j.ejmech.2026.119105_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313955","article-title":"Recent advances in material technology for leukemia treatments","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119105_bib111","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.annonc.2022.11.004","article-title":"Moving toward individualized target-based therapies in acute myeloid leukemia","volume":"34","author":"Bazinet","year":"2023","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119105_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119105_bib113","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood.2024026312","article-title":"Novel treatment strategies for chronic myeloid leukemia","volume":"145","author":"Cruz-Rodriguez","year":"2025","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119105_bib114","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.trecan.2022.06.009","article-title":"Drug independence and the curability of cancer by combination chemotherapy","volume":"8","author":"Pomeroy","year":"2022","journal-title":"Trends Cancer"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib115","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1039\/D1CS00755F","article-title":"Delivery strategies in treatments of leukemia","volume":"51","author":"Ci","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119105_bib116","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and treatment of chronic lymphocytic leukemia: a review","volume":"329","author":"Shadman","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119105_bib117","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000914","article-title":"An overview of targeted therapies in acute myeloid leukemia","volume":"7","author":"Turkalj","year":"2023","journal-title":"HemaSphere"},{"key":"10.1016\/j.ejmech.2026.119105_bib118","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jorganchem.2013.07.077","article-title":"Synthesis and mechanistic insight of glycosylated CuII\/NiII\u2013Sn2IV heterobimetallic DNA binding agents: validation of a specific CuII\u2013Sn2IV chemotherapeutic agent for human leukemic cell line K-562","volume":"745","author":"Tabassum","year":"2013","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2026.119105_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117756","article-title":"Acetylated galactopyranosyl N-heterocyclic monocarbene complexes of Silver(I) as novel anti-proliferative agents in a rhabdomyosarcoma cell line","volume":"107","author":"Hobsteter","year":"2024","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:42Z","timestamp":1787040282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":119,"alternative-id":["S0223523426005507"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119105","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of glycoconjugated metal complexes in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119105"}}